Related Experiment Video
Updated: Jul 10, 2025
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
11.9K
Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research
Sara J Cromer1,2,3, Barbara Steiner2, Cassie York3
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Pharmacoepidemiology and Drug Safety
|November 20, 2023
Summary
Engaging diverse stakeholders in complex pharmacoepidemiologic research is feasible and beneficial. Patient and clinician involvement enhanced study design and dissemination, demonstrating the value of stakeholder participation in advancing health research.
Area of Science:
- Pharmacoepidemiology
- Health Services Research
- Patient Engagement
Background:
- Pharmacoepidemiologic research often involves complex methodologies.
- Stakeholder engagement in this field is not well-documented.
- There is a need to understand how to effectively involve stakeholders in rigorous research.
Purpose of the Study:
- To describe an approach for engaging stakeholders in a multi-year pharmacoepidemiologic research program.
- To share lessons learned from involving patients and clinicians with varying research experience.
- To evaluate the impact of stakeholder engagement on research quality and outcomes.
Main Methods:
- Recruited and compensated patient and clinician stakeholders.
- Provided training in observational research and pharmacoepidemiologic methods.
- Conducted virtual stakeholder meetings 2-3 times annually with preparatory materials.
Main Results:
- High attendance (89%-100%) and engagement from all stakeholders.
- Stakeholders reported positive experiences, satisfaction, and dedication.
- Contributions included prioritizing research questions, optimizing evidence briefs, and advising on dissemination.
Conclusions:
- Stakeholder engagement is feasible and acceptable in complex pharmacoepidemiologic research.
- Engagement positively impacts research projects, from design to dissemination.
- This approach enhances the relevance and applicability of research findings.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:12Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:26Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K